Use of stem cells for research has not be conducted without its share of controversy. New research using a new transplant method involving umbilical cord blood, presented at this year’s virtual Conference on Retroviruses and Opportunistic Infections (February 12-16), provides hope for placing more people living with HIV in remission. More notably, this research has the potential for impacting the lives of those with racially diverse backgrounds.
Read more about the groundbreaking research in this article courtesy of the New York Times:
https://www.nytimes.com/2022/02/15/health/hiv-cure-cord-blood.html
The official National Institutes of Health (NIH) news release is accessible here: